跳至主要内容
临床试验/NL-OMON29979
NL-OMON29979尚未招募不适用

OSTRADAMUS: Testing for thrombophilia in patients with a first episode of venous thromboembolism: a randomized controlled trial to assess effects on clinical outcomes, quality of life, and costs - NOSTRADAMUS

Academisch Medisch Centrum0 个研究点目标入组 1,336 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
1,336

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1) Subjects must be willing and able to give written informed consent
  • 2) Confirmed symptomatic DVT, i.e., proximal vein or extensive calf-vein
  • thrombosis, involving at least the upper third part of the deep calf veins (trifurcation, AND/OR confirmed symptomatic PE, no longer than 2 months prior to randomization
  • 3) age 18 years or older

排除标准

  • 1. Previous episodes of DVT or PE
  • 2. Active bleeding or high risk for bleeding contraindicating treatment with LMWH, fondaparinux or VKA
  • 3. Insertion of a caval filter to treat the episode of VTE
  • 4. Active cancer or anti-cancer treatment in the 6 months prior to the acute episode of VTE
  • 5. Life expectancy < 18 months
  • 6. Arterial thrombotic events in the context of a confirmed antiphospholipid antibody syndrome
  • 7. Indications for VKA other than DVT

研究者

相似试验